Divi’s Laboratories Limited reported a strong set of financial results for Q3 FY25, with the company registering a profit of ₹589 crore, marking a significant 65% year-on-year (YoY) growth compared to ₹358 crore in the same quarter of the previous year. The impressive growth was driven by higher revenue and efficient cost management.
Key Highlights:
- Revenue: The company’s revenue from operations for the quarter stood at ₹2,319 crore, a 25% YoY increase from ₹1,855 crore in Q3 FY24. Sequentially, revenue saw a slight dip compared to ₹2,338 crore in Q2 FY25.
- Total Income: Including other income of ₹82 crore, the total income for the quarter amounted to ₹2,401 crore, compared to ₹1,950 crore in the year-ago period.
- Expenses: Total expenses increased to ₹1,675 crore from ₹1,461 crore in Q3 FY24, driven mainly by a higher cost of materials consumed, which rose to ₹1,021 crore from ₹794 crore last year.
- Profit Before Tax (PBT): PBT surged to ₹726 crore from ₹489 crore in Q3 FY24, reflecting strong operational performance.
- Tax Expense: The company recorded a total tax expense of ₹137 crore during the quarter, down from ₹212 crore in the previous quarter.
- Net Profit: The net profit of ₹589 crore is a result of improved operational efficiency and robust revenue growth.
Nine-Month Performance:
For the nine months ended December 31, 2024, the company reported:
- Revenue from operations: ₹6,775 crore, compared to ₹5,542 crore in the previous year.
- Net profit: ₹1,529 crore, a notable increase from ₹1,062 crore in the nine-month period of the previous fiscal.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.